Literature DB >> 1938614

Structure of aureobasidin A.

K Ikai1, K Takesako, K Shiomi, M Moriguchi, Y Umeda, J Yamamoto, I Kato, H Naganawa.   

Abstract

Aureobasidin A, a new antifungal antibiotic, was isolated from the culture medium of Aureobasidium pullulans R106. Aureobasidin A was a cyclic depsipeptide consisting of eight alpha-amino acid units and one hydroxy acid unit. The structures of the units were found by acid hydrolysis of the antibiotic to be 2(R)-hydroxy-3(R)-methylpentanoic acid, beta-hydroxy-N-methyl-L-valine, N-methyl-L-valine, L-proline, allo-L-isoleucine, N-methyl-L-phenylalanine, L-leucine, and L-phenyl-alanine. The sequence of the units was identified by NMR and FAB-MS of the products from the alkaline hydrolysis of aureobasidin A.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1938614     DOI: 10.7164/antibiotics.44.925

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  17 in total

1.  Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast.

Authors:  Y Sun; R Taniguchi; D Tanoue; T Yamaji; H Takematsu; K Mori; T Fujita; T Kawasaki; Y Kozutsumi
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

3.  Role of ABC transporters in aureobasidin A resistance.

Authors:  A Ogawa; T Hashida-Okado; M Endo; H Yoshioka; T Tsuruo; K Takesako; I Kato
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species.

Authors:  W Zhong; M W Jeffries; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae.

Authors:  M Endo; K Takesako; I Kato; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

6.  Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Wagner B Dias; Lucia Mendonça-Previato; José O Previato; Norton Heise
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

7.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

8.  AUR1, a novel gene conferring aureobasidin resistance on Saccharomyces cerevisiae: a study of defective morphologies in Aur1p-depleted cells.

Authors:  T Hashida-Okado; A Ogawa; M Endo; R Yasumoto; K Takesako; I Kato
Journal:  Mol Gen Genet       Date:  1996-05-23

9.  The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337).

Authors:  S A Heidler; J A Radding
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 10.  Antimicrobial Peptides and Proteins: From Nature's Reservoir to the Laboratory and Beyond.

Authors:  Tanumoy Sarkar; Monikha Chetia; Sunanda Chatterjee
Journal:  Front Chem       Date:  2021-06-18       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.